/AROC.ST
AROC.ST Stock - AroCell AB (publ)
Healthcare|Medical - Diagnostics & ResearchSTO
$0.57+0.00%
+$0.00 (+0.00%) • May 26
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.68
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.72
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.63
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AROC.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.57 – $0.58
TARGET (TP)$0.66
STOP LOSS$0.53
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.21
52W High$0.66
52W Low$0.35
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $57.44M | $43.04M | $36.99M | $12.00M | $84,000 |
| Gross Profit | $11.73M | $-2,102,000 | $-2,105,000 | $-5,045,000 | $63,000 |
| Gross Margin | 20.4% | -4.9% | -5.7% | -42.1% | 75.0% |
| Operating Income | $-43,430,000 | $-59,784,000 | $-59,304,000 | $-50,573,000 | $-24,052,000 |
| Net Income | $-42,449,000 | $-59,297,000 | $-58,973,000 | $-50,026,000 | $-19,459,000 |
| Net Margin | -73.9% | -137.8% | -159.4% | -417.0% | -23165.5% |
| EPS | $-0.18 | $-0.26 | $-0.27 | $-0.52 | $-0.26 |
Company Overview
AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is based in Uppsala, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
AROC.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.05
Q2 2025
EPS Surprise History
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | May 7, 2025 | — | $-0.05 | — | — |
Q1 2025 | Feb 19, 2025 | — | $-0.04 | — | — |
Q4 2024 | Oct 24, 2024 | — | $-0.04 | — | — |
Q3 2024 | Aug 21, 2024 | — | $-0.06 | — | — |
Q2 2024 | May 3, 2024 | — | $-0.05 | — | — |
Q1 2024 | Feb 22, 2024 | — | $-0.07 | — | — |
Q4 2023 | Nov 2, 2023 | — | $-0.06 | — | — |
Q3 2023 | Aug 23, 2023 | — | $-0.07 | — | — |
Q2 2023 | May 3, 2023 | — | $-0.06 | — | — |
Q1 2023 | Feb 23, 2023 | — | $-0.07 | — | — |
Q4 2022 | Oct 27, 2022 | — | $-0.05 | — | — |
Q3 2022 | Aug 17, 2022 | — | $-0.07 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-0.09 | — | — |
Q1 2022 | Feb 24, 2022 | — | $-0.24 | — | — |
Q4 2021 | Nov 12, 2021 | — | $-0.20 | — | — |
Q3 2021 | Aug 31, 2021 | — | $-0.09 | — | — |
Q2 2021 | May 12, 2021 | — | $-0.08 | — | — |
Q1 2021 | Feb 19, 2021 | — | $-0.08 | — | — |
Q4 2020 | Nov 19, 2020 | — | $-0.08 | — | — |
Q3 2020 | Aug 20, 2020 | — | $-0.08 | — | — |
Latest News
Loading news...
Frequently Asked Questions about AROC.ST
What is AROC.ST's current stock price?
AroCell AB (publ) (AROC.ST) is currently trading at $0.57 per share. The stock has moved +0.00% today.
What is the analyst price target for AROC.ST?
No analyst price targets are currently available for this stock.
What sector is AroCell AB (publ) in?
AroCell AB (publ) operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the STO exchange.
What is AROC.ST's market cap?
AroCell AB (publ) has a market capitalization of $0.13 billion, making it a small-cap company.
Does AROC.ST pay dividends?
No, AroCell AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAEGIR.ST
AegirBio AB (publ)
$0.43
Mkt Cap: $0.0B
COMBI.ST
CombiGene AB (publ)
$2.47
Mkt Cap: $0.0B
DIGN.ST
Dignitana AB (publ)
$2.14
Mkt Cap: $0.2B
EMPLI.ST
Emplicure AB (publ)
$0.47
Mkt Cap: $0.0B
FRISQ.ST
FRISQ Holding AB (publ)
$0.70
Mkt Cap: $0.0B
IRRAS.ST
IRRAS AB (publ)
$0.16
Mkt Cap: $0.2B
ISR.ST
ISR Immune System Regulation Holding AB (publ)
$1.40
Mkt Cap: $0.1B
LIPI.ST
Lipidor AB (publ)
$0.21
Mkt Cap: $0.2B
RLS.ST
RLS Global AB (publ)
$0.45
Mkt Cap: $0.0B
TOL.ST
Toleranzia AB
$0.48
Mkt Cap: $0.1B
Explore stocks similar to AROC.ST for comparison